Erika Hamilton
MD
Director, Breast Cancer and Gynecologic Cancer Research
👥Biography 个人简介
Erika Hamilton is a prolific phase I/II clinical trialist who has been instrumental in the early clinical development of trastuzumab deruxtecan and numerous other ADCs for breast cancer. Her research at Sarah Cannon has accelerated the development pipeline for breast cancer therapeutics. She leads innovative basket trials and combination studies across breast cancer subtypes.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Erika Hamilton 的研究动态
Follow Erika Hamilton's research updates
留下邮箱，当我们发布与 Erika Hamilton（Sarah Cannon Research Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment